Cancer therapy targeted at cellular signal transduction mechanisms: strategies, clinical results, and unresolved issues.

作者: Thoralf Christoffersen , Tormod K Guren , Karen-Lise Garm Spindler , Olav Dahl , Per Eystein Lønning

DOI: 10.1016/J.EJPHAR.2009.10.009

关键词:

摘要: Much effort is currently being spent on developing anticancer drugs targeted at cellular signal transduction mechanisms, and several signal inhibitors have also been introduced …

参考文章(224)
Jeffrey W. Pollard, Tumour-educated macrophages promote tumour progression and metastasis Nature Reviews Cancer. ,vol. 4, pp. 71- 78 ,(2004) , 10.1038/NRC1256
Adrian L. Harris, Hypoxia — a key regulatory factor in tumour growth Nature Reviews Cancer. ,vol. 2, pp. 38- 47 ,(2002) , 10.1038/NRC704
Napoleone Ferrara, Kenneth J Hillan, Hans-Peter Gerber, William Novotny, None, Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer Nature Reviews Drug Discovery. ,vol. 3, pp. 391- 400 ,(2004) , 10.1038/NRD1381
Andreas Gschwind, Oliver M. Fischer, Axel Ullrich, The discovery of receptor tyrosine kinases: targets for cancer therapy. Nature Reviews Cancer. ,vol. 4, pp. 361- 370 ,(2004) , 10.1038/NRC1360
Timothy S. Lewis, Paul S. Shapiro, Natalie G. Ahn, Signal Transduction through MAP Kinase Cascades Advances in Cancer Research. ,vol. 74, pp. 49- 139 ,(1998) , 10.1016/S0065-230X(08)60765-4
Peter Blume-Jensen, Tony Hunter, Oncogenic kinase signalling. Nature. ,vol. 411, pp. 355- 365 ,(2001) , 10.1038/35077225
Lance A. Liotta, Elise C. Kohn, The microenvironment of the tumour-host interface Nature. ,vol. 411, pp. 375- 379 ,(2001) , 10.1038/35077241
Kamran Ghoreschi, Arian Laurence, John J O'Shea, Selectivity and therapeutic inhibition of kinases: to be or not to be? Nature Immunology. ,vol. 10, pp. 356- 360 ,(2009) , 10.1038/NI.1701
Frank McCormick, Small-molecule inhibitors of cell signaling. Current Opinion in Biotechnology. ,vol. 11, pp. 593- 597 ,(2000) , 10.1016/S0958-1669(00)00149-X